1l2j
Human Estrogen Receptor beta Ligand-binding Domain in Complex with (R,R)-5,11-cis-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol
|
OverviewOverview
The R,R enantiomer of, 5,11-cis-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol (THC) exerts, opposite effects on the transcriptional activity of the two estrogen, receptor (ER) subtypes, ER alpha and ER beta. THC acts as an ER alpha, agonist and as an ER beta antagonist. We have determined the crystal, structures of the ER alpha ligand binding domain (LBD) bound to both THC, and a fragment of the transcriptional coactivator GRIP1, and the ER beta, LBD bound to THC. THC stabilizes a conformation of the ER alpha LBD that, permits coactivator association and a conformation of the ER beta LBD that, prevents coactivator association. A comparison of the two structures, taken together with functional data, reveals that THC does not act on ER, beta through the same mechanisms used by other known ER antagonists., Instead, THC antagonizes ER beta through a novel mechanism we term, 'passive antagonism'.
About this StructureAbout this Structure
1L2J is a Single protein structure of sequence from Homo sapiens with ETC as ligand. Full crystallographic information is available from OCA.
ReferenceReference
Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism., Shiau AK, Barstad D, Radek JT, Meyers MJ, Nettles KW, Katzenellenbogen BS, Katzenellenbogen JA, Agard DA, Greene GL, Nat Struct Biol. 2002 May;9(5):359-64. PMID:11953755
Page seeded by OCA on Mon Nov 12 17:56:33 2007